Invitae changes leadership, lays off 1,000 workers

Medical genetics company Invitae is restructuring leadership and laying off 1,000 employees. 

Securities and Exchange Commission filings show that Invitae is looking to restructure its business and implement cost-reduction measures by prioritizing its genome sequencing and genome management platforms. Invitae's chief operating officer, Kenneth Knight, will be stepping into the CEO role, replacing Sean George, PhD, according to the July 16 SEC filing. 

The layoffs of more than 1,000 positions will generate $152 million for Invitae in savings. The company is also expected to consolidate office and lab space to generate further savings.

Read the full SEC filing here.

Copyright © 2022 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Whitepapers

Featured Webinars